Analyze Diet

Topic:Pharmaceuticals

Pharmaceuticals in equine medicine encompass a wide range of drugs and therapeutic agents used to treat various conditions in horses. These substances include analgesics, anti-inflammatories, antibiotics, sedatives, and anthelmintics, among others. Each class of pharmaceuticals is designed to address specific health issues, such as pain management, infection control, or parasitic infestations. The pharmacokinetics and pharmacodynamics of these drugs can vary significantly between horses and other species, necessitating careful consideration of dosage and administration methods. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, safety, and regulatory aspects of pharmaceuticals used in equine healthcare.
Equine hepatocytes: isolation, cryopreservation, and applications to in vitro drug metabolism studies.
Pharmacology research & perspectives    September 30, 2016   Volume 4, Issue 5 e00268 doi: 10.1002/prp2.268
Shibany KA, Tötemeyer S, Pratt SL, Paine SW.Despite reports of the successful isolation of primary equine hepatocytes, there are no published data regarding the successful cryopreservation of these isolated cells. In this study, a detailed description of the procedures for isolation, cryopreservation, and recovery of equine hepatocytes are presented. Furthermore, the intrinsic clearance (Cl) and production of metabolites for three drugs were compared between freshly isolated and recovered cryopreserved hepatocytes. Primary equine hepatocytes were isolated using a two-step collagenase perfusion method, with an average cell yield of 2.47Â...
Pharmacokinetic profiles of the active metamizole metabolites in healthy horses.
Journal of veterinary pharmacology and therapeutics    July 31, 2016   Volume 40, Issue 2 165-171 doi: 10.1111/jvp.12342
Giorgi M, Aupanun S, Lee HK, Poapolathep A, Rychshanova R, Vullo C, Faillace V, Laus F.Metamizole (MT) is an analgesic and antipyretic drug labelled for use in humans, horses, cattle, swine and dogs. MT is rapidly hydrolysed to the active primary metabolite 4-methylaminoantipyrine (MAA). MAA is formed in much larger amounts compared with other minor metabolites. Among the other secondary metabolites, 4-aminoantipyrine (AA) is also relatively active. The aim of this research was to evaluate the pharmacokinetic profiles of MAA and AA after dose of 25 mg/kg MT by intravenous (i.v.) and intramuscular (i.m.) routes in healthy horses. Six horses were randomly allocated to two equally...
Analysis of phenylbutazone residues in horse tissues with and without enzyme-hydrolysis by LC-MS/MS.
Drug testing and analysis    July 23, 2016   Volume 8, Issue 5-6 535-538 doi: 10.1002/dta.2020
Boison JO, Dowling T, Johnson R, Kinar J.Phenylbutazone (PBZ) is permitted to be used for the treatment of musculoskeletal pain and inflammation in race horses but it is not approved for use in horses destined for human consumption. In a recent study initiated in our laboratory to study the disposition of PBZ and its oxyphenbutazone (OXPBZ) metabolite in equine tissues, we compared the effect of an additional enzymatic hydrolysis step with ß-glucuronidase on the results of the analysis for PBZ without enzymatic hydrolysis. Incurred tissue samples obtained from a female horse dosed with PBZ at 8.8 mg/kg for 3 days and sacrificed ...
In vitro analysis of the effect of supplementation with activated charcoal on the equine hindgut.
Journal of equine science    June 21, 2016   Volume 27, Issue 2 49-55 doi: 10.1294/jes.27.49
Edmunds JL, Worgan HJ, Dougal K, Girdwood SE, Douglas JL, McEwan NR.The present study uses in vitro analytical techniques to investigate the effect of activated charcoal on the microbial community of the equine hindgut and the metabolites they produce. Incubations were performed in Wheaton bottles using a 50 ml incubation of a high-energy feed or a low-energy feed, plus bottles with no added food source, together with five levels of activated charcoal (0, 10, 25, 50 or 100 mg per bottle) and fecal samples as a bacterial inoculum. Using this method the rate of gas production, volatile fatty acid and ammonia concentrations, and pH values were analyzed and found ...
Long-term monitoring of opioid, sedative and anti-inflammatory drugs in horse hair using a selective and sensitive LC-MS/MS procedure.
BMC veterinary research    June 1, 2016   Volume 12 84 doi: 10.1186/s12917-016-0709-5
Madry MM, Spycher BS, Kupper J, Fuerst A, Baumgartner MR, Kraemer T, Naegeli H.Compared to blood or urine, drugs can be detected for much longer periods in the long hair of horses. The aim of this study was to establish and validate a highly sensitive liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the detection and quantification of frequently prescribed opioids, sedatives and non-steroidal anti-inflammatory agents in the mane and tail hair of horses. Based on an average growth rate of about 2 cm per month, times of administration reported by horse owners or veterinary physicians were related to drug localizations in hair. Hair samples were collecte...
[New drugs for horses and production animals in 2015].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    May 24, 2016   Volume 44, Issue 3 164-170 doi: 10.15653/TPG-160400
Emmerich IU.In 2015, four newly developed active pharmaceutical ingredients for horses and food-producing animals were released on the German market for veterinary drug products. These were the bisphosphonate Clodronic Acid (Osphos®), the 5-hydroxytryptamine (2A) receptor antagonist Ketanserin (Vulketan®), the aminoglycoside antibiotic Paromomycin (Parofor®) and the antibiotic Thiamphenicol (TAF Spray®) from the fenicole group. With Chlorphenamine, a temporary not available active ingredient was reapproved in a new drug. Furthermore, three veterinary drugs with a new formulation as well as one product...
Doping control analysis of 46 polar drugs in horse plasma and urine using a ‘dilute-and-shoot’ ultra high performance liquid chromatography-high resolution mass spectrometry approach.
Journal of chromatography. A    May 3, 2016   Volume 1451 41-49 doi: 10.1016/j.chroma.2016.05.002
Kwok WH, Choi TLS, Kwok KY, Chan GHM, Wong JKY, Wan TSM.The high sensitivity of ultra high performance liquid chromatography coupled with high resolution mass spectrometry (UHPLC-HRMS) allows the identification of many prohibited substances without pre-concentration, leading to the development of simple and fast 'dilute-and-shoot' methods for doping control for human and equine sports. While the detection of polar drugs in plasma and urine is difficult using liquid-liquid or solid-phase extraction as these substances are poorly extracted, the 'dilute-and-shoot' approach is plausible. This paper describes a 'dilute-and-shoot' UHPLC-HRMS screening me...
Elimination of cetirizine following administration of multiple doses to exercised thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    April 28, 2016   Volume 39, Issue 5 522-524 doi: 10.1111/jvp.12318
Knych HK, Stanley SD, Arthur RM, McKemie DS.Cetirizine is an antihistamine used in performance horses for the treatment of hypersensitivity reactions and as such a withdrawal time is necessary prior to competition. The objective of the current study was to describe the disposition and elimination of cetirizine following oral administration in order to provide additional serum concentration data upon which appropriate regulatory recommendations can be established. Nine exercised thoroughbred horses were administered 0.4 mg/kg of cetirizine orally BID for a total of five doses. Blood samples were collected immediately prior to drug admin...
Nickel in equine sports drug testing – pilot study results on urinary nickel concentrations.
Rapid communications in mass spectrometry : RCM    March 13, 2016   Volume 30, Issue 7 982-984 doi: 10.1002/rcm.7528
Thevis M, Machnik M, Schenk I, Krug O, Piper T, Schänzer W, Düe M, Bondesson U, Hedeland M.The issue of illicit performance enhancement spans human and animal sport in presumably equal measure, with prohibited substances and methods of doping conveying both ways. Due to the proven capability of unbound ionic cobalt (Co(2) (+) ) to stimulate erythropoiesis in humans, both human and equine anti-doping regulations have listed cobalt as a banned substance, and in particular in horse drug testing, thresholds for cobalt concentrations applying to plasma and urine have been suggested or established. Recent reports about the finding of substantial amounts of undeclared nickel in arguably li...
Investigation of the selective androgen receptor modulators S1, S4 and S22 and their metabolites in equine plasma using high-resolution mass spectrometry.
Rapid communications in mass spectrometry : RCM    March 13, 2016   Volume 30, Issue 7 833-842 doi: 10.1002/rcm.7512
Hansson A, Knych H, Stanley S, Thevis M, Bondesson U, Hedeland M.Selective androgen receptor modulators (SARMs) are prohibited in sports due to their performance enhancing ability. It is important to investigate the metabolism to determine appropriate targets for doping control. This is the first study where the equine metabolites of SARMs S1, S4 (Andarine) and S22 (Ostarine) have been studied in plasma. Methods: Each SARM was administered to three horses as an intravenous bolus dose and plasma samples were collected. The samples were pretreated with protein precipitation using cold acetonitrile before separation by liquid chromatography. The mass spectrome...
In vivo and in vitro metabolism of the designer anabolic steroid furazadrol in thoroughbred racehorses.
Journal of pharmaceutical and biomedical analysis    February 26, 2016   Volume 124 198-206 doi: 10.1016/j.jpba.2016.02.031
Waller CC, Cawley AT, Suann CJ, Ma P, McLeod MD.Furazadrol ([1',2']isoxazolo[4',5':2,3]-5α-androstan-17β-ol) is a designer anabolic androgenic steroid that is readily available via the internet. It contains an isoxazole fused to the steroid A-ring which offers metabolic stability and noteworthy anabolic activity raising concerns over the potential for abuse of this compound in equine sports. The metabolism of furazadrol was studied by in vivo and in vitro methods for the first time. Urinary furazadrol 17-sulfate and furazadrol 17-glucuronide metabolites were detected in vivo after a controlled administration and compared with syntheticall...
Inflammatory Airway Disease of Horses–Revised Consensus Statement.
Journal of veterinary internal medicine    January 24, 2016   Volume 30, Issue 2 503-515 doi: 10.1111/jvim.13824
Couëtil LL, Cardwell JM, Gerber V, Lavoie JP, Léguillette R, Richard EA.The purpose of this manuscript is to revise and update the previous consensus statement on inflammatory airway disease (IAD) in horses. Since 2007, a large number of scientific articles have been published on the topic and these new findings have led to a significant evolution of our understanding of IAD.
Pharmacokinetics of guaifenesin following administration of multiple doses to exercised Thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    January 14, 2016   Volume 39, Issue 4 416-419 doi: 10.1111/jvp.12287
Knych HK, Stanley SD, Benson D, Arthur RM.Guaifenesin is an expectorant commonly used in performance horses to aid in the clearance of mucus from the airways. Guaifenesin is also a centrally acting skeletal muscle relaxant and as such is a prohibited drug with withdrawal necessary prior to competition. To the authors' knowledge, there are no reports in the literature describing single or multiple oral administrations of guaifenesin in the horse to determine a regulatory threshold and related withdrawal time. Therefore, the objective of the current study was to describe the pharmacokinetics of guaifenesin following oral administration ...
[New causes of animal poisoning in Switzerland].
Schweizer Archiv fur Tierheilkunde    January 13, 2016   Volume 157, Issue 3 147-152 doi: 10.17236/sat00011
Schediwy M, Mevissen M, Demuth D, Kupper J, Naegeli H.This retrospective study evaluated the frequency, etiology, therapy and prognosis of animal poisoning registered from 2003 to 2012. The relevant cases reported to the Swiss Toxicological Information Center (STIC) were compared with those from previously examined periods. Human medicines not approved for animals and pesticides represented the most common causes of poisoning in dogs. Novel cases occurred as a consequence of the exposure of dogs to ricinus fertilizers, grape residues from wineries, pepper lachrymatory spray and dry bouillon. Cats are still freequently poisoned by pyrethroid drugs...
FDA surveying veterinarians on antiparasitic drug resistance.
Journal of the American Veterinary Medical Association    November 26, 2015   Volume 247, Issue 6 585 
Cima G.No abstract available
Erratum to: Sequence Elucidation of an Unknown Cyclic Peptide of High Doping Potential by ETD and CID Tandem Mass Spectrometry.
Journal of the American Society for Mass Spectrometry    October 29, 2015   Volume 27, Issue 2 370 doi: 10.1007/s13361-015-1294-8
Guan F, Uboh CE, Soma LR, Rudy J.No abstract available
Detection of the selective androgen receptor modulator andarine (S-4) in a routine equine blood doping control sample.
Drug testing and analysis    October 12, 2015   Volume 8, Issue 2 257-261 doi: 10.1002/dta.1867
Cawley AT, Smart C, Greer C, Liu Lau M, Keledjian J.No abstract available
Pharmacokinetics of ketorolac tromethamine in horses after intravenous, intramuscular, and oral single-dose administration.
Journal of veterinary pharmacology and therapeutics    September 28, 2015   Volume 39, Issue 2 167-175 doi: 10.1111/jvp.12260
Bianco AW, Constable PD, Cooper BR, Taylor SD.Nonsteroidal anti-inflammatory drugs (NSAIDs) are an integral component of equine analgesia, yet currently available NSAIDs are both limited in their analgesic efficacy and have adverse effects. The NSAID ketorolac tromethamine (KT) is widely used in humans as a potent morphine-sparing analgesic drug but has not been fully evaluated in horses. The purpose of this study was to determine the pharmacokinetic profile of KT in horses after intravenous (i.v.), intramuscular (i.m.), and oral (p.o.) administration. Nine healthy adult horses received a single 0.5-mg/kg dose of KT via each route of admi...
Metabolic studies of oxyguno in horses.
Analytica chimica acta    August 24, 2015   Volume 891 190-202 doi: 10.1016/j.aca.2015.08.006
Wong AS, Ho EN, Wan TS, Lam KK, Stewart BD.Oxyguno (4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione) is a synthetic oral anabolic androgenic steroid commercially available without a prescription. Manufacturers of oxyguno claim that its anabolic effect in metabolic enhancement exceeds that of the classic anabolic steroid testosterone by seven times, but its androgenic side-effects are only twelve percent of testosterone. Like other anabolic androgenic steroids, oxyguno is prohibited in equine sports. The metabolism of oxyguno in either human or horse has not been reported and therefore little is known about its metabolic fate...
Pharmacokinetics and bioequivalence of 2 meloxicam oral dosage formulations in healthy adult horses.
The Canadian veterinary journal = La revue veterinaire canadienne    July 2, 2015   Volume 56, Issue 7 730-736 
Vivancos M, Barker J, Engbers S, Fischer C, Frederick J, Friedt H, Rybicka JM, Stastny T, Banse H, Cribb AE.Meloxicam, a non-steroidal anti-inflammatory drug, is approved for use in horses in several countries, but an equine formulation is not available in North America. However, meloxicam is being used in an extra-label manner in horses in Canada. The purpose of this study, therefore, was to assess the bioequivalence of an approved oral meloxicam suspension (Metacam 15 mg/mL for horses; Boehringer Ingelheim Vetmedica GmBH, Ingelheim, Germany) from the European Union with human meloxicam tablets (Meloxicam 15 mg tablets; TEVA Canada, Toronto, Ontario) compounded with molasses to improve palatability...
Liquid chromatography-mass spectrometry analysis of five bisphosphonates in equine urine and plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences    June 20, 2015   Volume 998-999 1-7 doi: 10.1016/j.jchromb.2015.06.020
Wong AS, Ho EN, Wan TS, Lam KK, Stewart BD.Bisphosphonates are used in the management of skeletal disorder in humans and horses, with tiludronic acid being the first licensed veterinary medicine in the treatment of lameness associated with degenerative joint disease. Bisphosphonates are prohibited in horseracing according to Article 6 of the International Agreement on Breeding, Racing and Wagering (published by the International Federation of Horseracing Authorities). In order to control the use of bisphosphonates in equine sports, an effective method to detect the use of bisphosphonates is required. Bisphosphonates are difficult-to-de...
Quantification of sodium pentobarbital residues from equine mortality compost piles.
Journal of animal science    May 29, 2015   Volume 93, Issue 4 1824-1829 doi: 10.2527/jas.2014-8193
Payne J, Farris R, Parker G, Bonhotal J, Schwarz M.Sodium pentobarbital, a euthanasia drug, can persist in animal carcasses following euthanasia and can cause secondary toxicosis to animals that consume the remains. This experiment was conducted to observe the effects of composting on euthanized horse carcass degradation and sodium pentobarbital residues in compost material up to 367 d. Six separate compost bins were constructed on pastureland. Three bins served as the control while 3 served as the treatment. The carbonaceous material, or bulking agent, consisted of hardwood chips mixed with yard waste wetted to approximately 50% moisture cont...
Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
The Journal of steroid biochemistry and molecular biology    May 29, 2015   Volume 152 142-154 doi: 10.1016/j.jsbmb.2015.05.011
Kwok WH, Leung GN, Wan TS, Curl P, Schiff PJ.Androsta-1,4,6-triene-3,17-dione (ATD) is an irreversible steroidal aromatase inhibitor and is marketed as a supplement. It has been reported to effectively reduce estrogen biosynthesis and significantly increase the levels of endogenous steroids such as dihydrotestosterone and testosterone in human. ATD abuses have been reported in human sports. Its metabolism in human has been studied, and the in vitro metabolic study of ATD in horses has been reported, however, little is known about its biotransformation and elimination in horses. This paper describes the in vitro and in vivo metabolism stu...
[New drugs for horses and production animals in 2014].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    May 27, 2015   Volume 43, Issue 3 154-158 doi: 10.15653/TPG-150250
Emmerich IU.In 2014, no new active pharmaceutical ingredients were released on the German market for horses and food producing animals. One established veterinary active pharmaceutical ingredient is avaibable for an additional species. The analgetic buprenorphine (Buprenodale® Multidose) has additionally been authorized for horses. Furthermore, four new preparations with a new pharmaceutical form, one drug with a new formulation, new galenics and a new indication, respectively, have recently been released to the market. Furthermore, the prostaglandin F2α analoque luprostiol is available again.
Chip-based nanoelectrospray ionization with Fourier transform mass spectrometric detection to screen for local anesthetics intended to mask limb sore in walking horses.
Journal of mass spectrometry : JMS    March 25, 2015   Volume 50, Issue 3 533-537 doi: 10.1002/jms.3558
Szarka S, Prokai L.We report a high-throughput chip-based nanoelectrospray ionization method coupled with Fourier transform mass spectrometry to screen for local anesthetics in samples collected by swabbing. These drugs have been used to mask pain on the limbs of walking horses after forbidden practices of soring or physical abuse. Optimized for lidocaine, the method afforded sub-ppm mass accuracy for nine local anesthetics included in the study. From doped cotton swabs, two third and all of the analytes were detected after adding 10 ng and 100 ng of each drug, respectively. Benzocaine and/or lidocaine were ...
Cerebral and brainstem electrophysiologic activity during euthanasia with pentobarbital sodium in horses.
Journal of veterinary internal medicine    March 19, 2015   Volume 29, Issue 2 663-672 doi: 10.1111/jvim.12570
Aleman M, Williams DC, Guedes A, Madigan JE.An overdose of pentobarbital sodium administered i.v. is the most commonly used method of euthanasia in veterinary medicine. Determining death after the infusion relies on the observation of physical variables. However, it is unknown when cortical electrical activity and brainstem function are lost in a sequence of events before death. Objective: To examine changes in the electrical activity of the cerebral cortex and brainstem during an overdose of pentobarbital sodium solution for euthanasia. Our testing hypothesis is that isoelectric pattern of the brain in support of brain death occurs bef...
The effect of feeding on the pharmacokinetic variables of two commercially available formulations of omeprazole.
Journal of veterinary pharmacology and therapeutics    February 10, 2015   Volume 38, Issue 5 500-503 doi: 10.1111/jvp.12210
Sykes BW, Underwood C, McGowan CM, Mills PC.The objectives of this study were to investigate the impact of formulation (enteric coated and buffered) and feeding on pharmacokinetic variables associated with the oral administration of omeprazole in the horse. Six thoroughbred racehorses were studied in a crossover design. Each received 2 g of an enteric coated or buffered formulation in both the fed and fasted state. Plasma omeprazole concentrations were determined by UHPLC-MS. The effects of feeding or formulation on AUC0-inf_obs, half-life, Tmax or Cmax were not statistically significant. However, a wider-than-expected degree of variati...
Regional intravenous limb perfusion compared to systemic intravenous administration for marimastat delivery to equine lamellar tissue.
Journal of veterinary pharmacology and therapeutics    January 30, 2015   Volume 38, Issue 4 392-399 doi: 10.1111/jvp.12198
Underwood C, Collins SN, Mills PC, Van Eps AW, Allavena RE, Medina Torres CE, Pollitt CC.Pharmaceutical agents with potential for laminitis prevention have been identified. Many of these, including the MMP inhibitor marimastat, are impractical for systemic administration. This study compared local delivery of marimastat by regional limb perfusion (RLP) to systemic intravenous bolus dosing (SIVB), and established whether RLP results in local lamellar drug delivery. Six adult horses received 0.23 mg/kg of marimastat by RLP followed by 0.23 mg/kg marimastat by SIVB, with a 24-h washout period. Lamellar ultrafiltration probes sampled lamellar interstitial fluid as lamellar ultrafiltra...
[Alimentary intake of opioid alkaloids by horses. Hazards due to poppy-containing feeds].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    January 27, 2015   Volume 43, Issue 1 35-43 doi: 10.15653/TPG-140638
Hertzsch R, Emmerich IU, Lachenmeier DW, Sproll C, Monakhova YB, Aboling S, Bachmann U, Vervuert I.Opioid alkaloids were identified in the urine of horses during an anti-doping control and in a case of intoxication. In both cases, it was suspected that the horses had ingested poppy-contaminated feed. To verify this suspicion, possible opioid alkaloid sources in Germany were identified through a literature research. Additionally, the contaminated feed was botanically and chemically analysed. The results indicated that both cases were most probably caused by the poppy in the feed. This highlights the previously underestimated risk of an intake of poppy-contaminated feed in horses. Recommendat...
Pharmacokinetics and effects on thromboxane B2 production following intravenous administration of flunixin meglumine to exercised thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    January 13, 2015   Volume 38, Issue 4 313-320 doi: 10.1111/jvp.12197
Knych HK, Arthur RM, McKemie DS, Chapman N.Flunixin meglumine is commonly used in horses for the treatment of musculoskeletal injuries. The current ARCI threshold recommendation is 20 ng/mL when administered at least 24 h prior to race time. In light of samples exceeding the regulatory threshold at 24 h postadministration, the primary goal of the study reported here was to update the pharmacokinetics of flunixin following intravenous administration, utilizing a highly sensitive liquid chromatography-mass spectrometry (LC-MS). An additional objective was to characterize the effects of flunixin on COX-1 and COX-2 inhibition when drug con...
1 7 8 9 10 11 37